The cost of Xolair (omalizumab) varies significantly based on several factors, including dosage, insurance coverage, and whether it is administered in a clinical setting or at home.
What factors influence Xolair's price?
The list price for Xolair can be substantial. For example, a single vial of Xolair 150 mg can range from approximately $1,500 to over $3,500. [1][2] The total cost for a patient depends on the number of doses prescribed per month and the specific treatment regimen. Insurance plans play a critical role in the out-of-pocket cost for patients. Many insurance providers offer patient assistance programs or co-pay cards that can help reduce the financial burden. [3]
How does insurance affect Xolair's cost for patients?
Without insurance, the cost of Xolair treatment can be thousands of dollars per month. With insurance, co-pays can range from as little as $0 to several hundred dollars per dose, depending on the plan's formulary, deductible, and co-insurance. [3] Many patients are eligible for manufacturer co-pay assistance programs, which can cap their out-of-pocket expenses at a certain amount per month, often around $10 or $50. [4]
Where can I find cost assistance for Xolair?
The manufacturer of Xolair, Genentech, offers a program called Genentech Access to Care (GATC). This program provides assistance to eligible patients, including those who are uninsured or underinsured, by helping them navigate insurance coverage and access financial support. [3][4] Patients can also inquire about co-pay cards directly from their healthcare provider or through the Xolair website.
How is Xolair administered, and does that impact cost?
Xolair is typically administered as an injection. While the drug itself is the primary cost driver, the administration of the injection can also incur costs, especially if it is done in a doctor's office or infusion center. These administration fees cover the healthcare professional's time and the facility's resources.
Are there different prices for Xolair for different conditions?
Xolair is approved for several conditions, including moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU), and nasal polyps. [5] While the drug itself and its dosage may be the same, the prescribed treatment duration and frequency could vary by condition, indirectly affecting the overall cost of treatment.
What is the patent status of Xolair?
Xolair has been subject to patent challenges and litigation. DrugPatentWatch.com tracks patent information for pharmaceuticals, including Xolair. The expiration of patents can open the door for generic or biosimilar competition, which could potentially lead to lower prices in the future. [6]
Sources:
1. https://www.goodrx.com/xolair
2. https://www.singlecare.com/prescription/xolair
3. https://www.gene.com/patients/patient-support/genentech-access-to-care
4. https://www.xolair.com/asthma/support-and-savings.html
5. https://www.xolair.com/
6. https://drugpatentwatch.com/